Safety and efficacy of combined use of low molecular weight heparin (enoxaparin, lovenox) and glycoprotein IIb/IIIa receptor antagonist (eptifibatide, integrelin) during nonemergent coronary and peripheral vascular intervention.

Autor: Khosla S, Kunjummen B, Guerrero M, Manda R, Razminia M, Trivedi A, Vidyarthi V, Elbazour M, Ahmed A, Lubell D, Khosla, Sandeep, Kunjummen, Binu, Guerrero, Mayra, Manda, Ravi, Razminia, Mansoor, Trivedi, Atul, Vidyarthi, Vasundhara, Elbazour, Monther, Ahmed, Aziz, Lubell, David
Zdroj: American Journal of Therapeutics; Nov2002, Vol. 9 Issue 6, p488-491, 4p
Databáze: Complementary Index